sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks 10074-G5

10074-G5

CAS No.:
413611-93-5
Catalog Number:
AG00C0XJ
Molecular Formula:
C18H12N4O3
Molecular Weight:
332.3129
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$91
- +
5mg
≥98%
1 week
United States
$135
- +
10mg
≥98%
1 week
United States
$179
- +
25mg
≥98%
1 week
United States
$283
- +
50mg
96%
1 week
United States
$457
- +
100mg
96%
1 week
United States
$757
- +
Product Description
Catalog Number:
AG00C0XJ
Chemical Name:
10074-G5
CAS Number:
413611-93-5
Molecular Formula:
C18H12N4O3
Molecular Weight:
332.3129
MDL Number:
MFCD00576774
IUPAC Name:
4-nitro-N-(2-phenylphenyl)-2,1,3-benzoxadiazol-7-amine
InChI:
InChI=1S/C18H12N4O3/c23-22(24)16-11-10-15(17-18(16)21-25-20-17)19-14-9-5-4-8-13(14)12-6-2-1-3-7-12/h1-11,19H
InChI Key:
KMJPYSQOCBYMCF-UHFFFAOYSA-N
SMILES:
[O-][N+](=O)c1ccc(c2c1non2)Nc1ccccc1c1ccccc1
Properties
Complexity:
466  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
332.091g/mol
Formal Charge:
0
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
332.319g/mol
Monoisotopic Mass:
332.091g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
96.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.2  
Literature
Title Journal
Synthetic cajanin stilbene acid derivatives inhibit c-MYC in breast cancer cells. Archives of toxicology 20160301
Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids. Oncotarget 20151020
Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion. Oncotarget 20150630
In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of 10074-G5, a novel small-molecule inhibitor of c-Myc/Max dimerization. The Journal of pharmacology and experimental therapeutics 20101201
Properties